Importer of Controlled Substances Notice of Registration, 77066 [E6-21895]
Download as PDF
<![CDATA[
77066
Federal Register / Vol. 71, No. 246 / Friday, December 22, 2006 / Notices
Dated: December 14, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–21896 Filed 12–21–06; 8:45 am]
DEPARTMENT OF JUSTICE
BILLING CODE 4410–09–P
Pursuant to § 1301.33(a) of Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on November 07,
2006, Organichem Corporation, 33
Riverside Avenue, Rensselaer, New
York 12144, made application by
renewal to the Drug Enforcement
Administration (DEA) as a bulk
manufacturer of the basic classes of
controlled substances listed in schedule
I and II:
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances
Notice of Registration
By Notice dated July 19, 2006, and
published in the Federal Register on
July 26, 2006, (71 FR 42417), Meridian
Medical Technologies, 255 Hermelin
Drive, St. Louis, Missouri 63144, made
application to the Drug Enforcement
Administration (DEA) to be registered as
an importer of Morphine (9300), a basic
class of controlled substance listed in
schedule II.
The company plans to import
products for research experimentation
or clinical use and analytical testing.
jlentini on PROD1PC65 with NOTICES
One objection was received; however,
it has subsequently been withdrawn.
DEA has considered the factors in 21
U.S.C. § 823(a) and § 952(a) and
determined that the registration of
Meridian Medical Technologies to
import the basic class of controlled
substances is consistent with the public
interest and with United States
obligations under international treaties,
conventions, or protocols in effect on
May 1, 1971, at this time. DEA has
investigated Meridian Medical
Technologies to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. § 952(a)
and § 958(a), and in accordance with 21
CFR § 1301.34, the above named
company is granted registration as an
importer of the basic class of controlled
substances listed.
Dated: December 14, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–21895 Filed 12–21–06; 8:45 am]
Drug Enforcement Administration
Manufacturer of Controlled
Substances Notice of Application
Drug
Schedule
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) .....
Amphetamine (1100) ....................
Methylphenidate (1724) ................
Pentobarbital (2270) .....................
Hydrocodone (9193) .....................
Meperidine(9230) .........................
Dextropropoxyphene (9273) .........
Fentanyl (9801) ............................
The company plans to manufacture
bulk controlled substances for use in
product development and for
distribution to its customers. In
reference to drug code 7360
(Marihuana), the company plans to bulk
manufacture cannabindiol as a synthetic
intermediate. This controlled substance
will be further synthesized to bulk
manufacture a synthetic THC (7370). No
other activity for this drug code is
authorized for this registration.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such a substance
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR § 1301.33(a).
Any such written comments or
objections being sent via regular mail
should be addressed, in quintuplicate,
to the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
Federal Register Representative/ODL; or
any being sent via express mail should
be sent to DEA Headquarters, Attention:
DEA Federal Register Representative/
ODL, 2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than February 20, 2007.
BILLING CODE 4410–09–P
VerDate Aug<31>2005
19:31 Dec 21, 2006
Jkt 211001
I
I
II
II
II
II
II
II
II
PO 00000
Frm 00107
Fmt 4703
Sfmt 4703
Dated:December 14, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–21886 Filed 12–21–06; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances Notice of Registration
By Notice dated July 25, 2006, and
published in the Federal Register on
July 31, 2006, (71 FR 43211), Penick
Corporation, 33 Industrial Park Road,
Pennsville, New Jersey 08070, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the basic classes of controlled
substances listed in schedule II:
Drug
Cocaine (9041) .............................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Ecgonine (9180) ...........................
Hydrocodone (9193) .....................
Morphine (9300) ...........................
Thebaine (9333) ...........................
Oxymorphone (9652) ...................
Schedule
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances as bulk
controlled substance intermediates for
distribution to its customers for further
manufacture or to manufacture
pharmaceutical dosage forms.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Penick Corporation to manufacture the
listed basic classes of controlled
substances is consistent with the public
interest at this time. DEA has
investigated Penick Corporation to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
E:\FR\FM\22DEN1.SGM
22DEN1
]]>Agencies
[Federal Register Volume 71, Number 246 (Friday, December 22, 2006)]
[Notices]
[Page 77066]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-21895]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances Notice of Registration
By Notice dated July 19, 2006, and published in the Federal
Register on July 26, 2006, (71 FR 42417), Meridian Medical
Technologies, 255 Hermelin Drive, St. Louis, Missouri 63144, made
application to the Drug Enforcement Administration (DEA) to be
registered as an importer of Morphine (9300), a basic class of
controlled substance listed in schedule II.
The company plans to import products for research experimentation
or clinical use and analytical testing.
One objection was received; however, it has subsequently been
withdrawn. DEA has considered the factors in 21 U.S.C. Sec. 823(a) and
Sec. 952(a) and determined that the registration of Meridian Medical
Technologies to import the basic class of controlled substances is
consistent with the public interest and with United States obligations
under international treaties, conventions, or protocols in effect on
May 1, 1971, at this time. DEA has investigated Meridian Medical
Technologies to ensure that the company's registration is consistent
with the public interest. The investigation has included inspection and
testing of the company's physical security systems, verification of the
company's compliance with state and local laws, and a review of the
company's background and history. Therefore, pursuant to 21 U.S.C.
Sec. 952(a) and Sec. 958(a), and in accordance with 21 CFR Sec.
1301.34, the above named company is granted registration as an importer
of the basic class of controlled substances listed.
Dated: December 14, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E6-21895 Filed 12-21-06; 8:45 am]
BILLING CODE 4410-09-P
